Mon, Sep 23 · 8:00

6th Technology Transfer for Biologics Conference provides attendees with an unequaled opportunity to study and improve fundamental, day-to-day management techniques. Our unmatched speaking faculty helps you to minimize variation between biologic runs at all production scales, maximize biologics quality and predictability, and accelerate commercialization.

Top Reasons to Attend:

* Reduce costs and risks while increasing the success rate for tech transfer
* Adapt technology transfer to respond to urgent medical issues
* Discuss best practice for creating a successful partnership with outsourced vendors
* Navigate the continuous manufacturing process for tech transfer
* Communication insight with internal and domestic partners
* Identify technical the application of the analytical method through project definition and gap analysis
* Discuss project and facility management to overcome geographic and cultural challenges

This event is ideal for:
* CMOs/CDMOs
* Technology Transfer/Commercialization Software
* Facilities/Engineering Specialists
* Lab Hardware/Reagent Providers
* Tech Transfer/Quality Control/Process Specialists

URLs:
Brochure: https://go.evvnt.com/439406-2?pid=5731 
Sponsor: https://go.evvnt.com/439406-3?pid=5731 

Prices:
Early Bird Pricing: USD 1895.0,
Standard: USD 2095.0,
Onsite: USD 2195.0

Speakers: Russell Beste Senior Director Global Process Development, MYLAN, Mitch Goetz Senior Engineer II, BIOGEN, Carin Gray Senior Engineer II, BIOGEN, Dr. Magdalena Leszczyniecka Chief Executive Officer, President, STC BIOLOGICS, Jim Leveron Senior Engineer, Manufacturing Sciences, IMMUNOGEN, Jody Logan Senior Manufacturing Technical Specialist, GENENTECH, Mark Ramsey Senior Manager MSAT, THERMO FISHER SCIENTIFIC, Jonathan Romero Director, Biologics Development and Manufacturing, CELGENE, Daniel Rudolph, Ph.D. Principal Engineer, Manufacturing Development, BioDefense Division, EMERGENT BIOSOLUTIONS, Adnan Sabir Principal Consultant, Pharma Consulting Services, Former Associate Director of QA, KOWA PHARMACEUTICALS, Dr. Zahra Shahrokh Chief Development Officer, STC BIOLOGICS